Sensera management no doubt have updated timelines and information from NanoDX regarding fixing the cartridge issue, commencing & completing data collection and likely submission timeframe for FDA EUA. They could share that information instead of just saying it's out of their hands. Sales reps are sharing that info publicly so I cant see why we can't be informed. Are management just lazy? Incompetent? Or going to support a TO? Why not help the share price by updating holders? Seems off IMO.
